FDA Inspection 727380 — Similasan AG

Similasan AG — FEI 1000110034

The FDA completed an inspection of Similasan AG on May 27, 2011 in Jonen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 27, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jonen (Switzerland)